Denali Therapeutics DNLI
NASDAQ DNLI
$19.84 -0.01 (-0.05%)
As of: Nov 11, 2026 · 12:47 PM EST

Denali Therapeutics (DNLI) Other Non Operating Income (2025 - 2026)

Updated

Denali Therapeutics' Other Non Operating Income came in at $196.88 million for Q3 2026, compared with $10.53 million a year earlier.

Analysis

Denali Therapeutics (DNLI) Other Non Operating Income (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Denali Therapeutics 3.18 Bn 98.89 Mn 17.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 196.88 Mn
Sep 30, 2025 10.53 Mn
API Access

Denali Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=DNLI&period=max&api_key=YOUR_API_KEY